Deal Announcements

Kythera Biopharmaceuticals Raises $40 Million Series C

Tuesday, May 20, 2008 5:56:00 AM PDT | VentureDeal Staff

CALABASAS, CA -- Biotechnology company Kythera Biopharmaceuticals, Inc. has announced that it has received $40 million in its third round of funding from a syndicate of venture capital firms.

Kythera is using the tools of biotechnology to develop prescription therapeutics for the emerging markets of aesthetic and restorative dermatology for aging populations.

Jafco Ventures America led the round, which included BBT Fund, Apothecary Capital, Versant Ventures, Arch Venture Partners, Prospect Venture Partners, Altitude Capital Partners and WS Investment.  The company said it would use the proceeds of this financing to complete Phase II trials for its lead product ATX-101.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1